Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6049)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. World J Gastroenterol 2015; 21(6): 1838-1844 [PMID: 25684949 DOI: 10.3748/wjg.v21.i6.1838] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i6/1838.htm |
| Number | Citing Articles |
| 1 |
Haruhiko Yamazaki, Tomoyuki Yokose, Hiroyuki Hayashi, Hiroyuki Iwasaki, Sachie Osanai, Nobuyasu Suganuma, Hirotaka Nakayama, Katsuhiko Masudo, Yasushi Rino, Munetaka Masuda. Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study. European Journal of Clinical Pharmacology 2020; 76(5): 703 doi: 10.1007/s00228-020-02842-y
|
| 2 |
Chang'an Sun, Lei Fang, Xiaobing Zhang, Peng Gao, Shaohua Gou. Novel 7-formyl-naphthyridyl-ureas derivatives as potential selective FGFR4 inhibitors: Design, synthesis, and biological activity studies. Bioorganic & Medicinal Chemistry 2019; 27(10): 1932 doi: 10.1016/j.bmc.2019.04.018
|
| 3 |
Mohamed A. Ahmed, Edgar Selzer, Wolfgang Dörr, Gerd Jomrich, Felix Harpain, Gerd R. Silberhumer, Leonhard Müllauer, Klaus Holzmann, Bettina Grasl-Kraupp, Michael Grusch, Walter Berger, Brigitte Marian. Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer. Oncotarget 2016; 7(43): 69976 doi: 10.18632/oncotarget.12099
|
| 4 |
Xiangjian Zhang, Xinxin Zhang, Ruokuo Han, Zhaojun Wang, Qiuhui Yang, Yiming Huang, Yuxiang Yan. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro. Biochemical and Biophysical Research Communications 2022; 595: 22 doi: 10.1016/j.bbrc.2022.01.067
|
| 5 |
Masakazu Yashiro, Tasuku Matsuoka. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer. World Journal of Gastroenterology 2016; 22(8): 2415-2423 doi: 10.3748/wjg.v22.i8.2415
|
| 6 |
Mikito Inokuchi, Hideaki Murase, Sho Otsuki, Tatsuyuki Kawano, Kazuyuki Kojima. Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-016-1081-4
|
| 7 |
Shengqian Zhu, Jinqin Mao, Yongfu Shao, Fang Chen, Xiaoqin Zhu, Dingli Xu, Xinjun Zhang, Junming Guo. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance. Tumor Biology 2015; 36(10): 8041 doi: 10.1007/s13277-015-3543-7
|
| 8 |
Masami Yamamoto, Sachiyo Nomura, Akihiro Hosoi, Koji Nagaoka, Tamaki Iino, Tomohiko Yasuda, Tomoko Saito, Hirokazu Matsushita, Eiji Uchida, Yasuyuki Seto, James R. Goldenring, Kazuhiko Kakimi, Masae Tatematsu, Tetsuya Tsukamoto. Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth. Cancer Science 2018; 109(5): 1480 doi: 10.1111/cas.13569
|
| 9 |
Mohammed Soutto, Xing Zhang, Nadeem Bhat, Zheng Chen, Shoumin Zhu, Selma Maacha, Melanie Genoula, Omar El-Gazzaz, Dunfa Peng, Heng Lu, Oliver G. McDonald, Xi Steven Chen, Longlong Cao, Zekuan Xu, Wael El-Rifai. Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis. Redox Biology 2024; 69: 102998 doi: 10.1016/j.redox.2023.102998
|